Barclays set a €114.20 ($132.79) target price on Hannover Re (FRA:HNR1) in a report published on Monday morning, Borsen Zeitung reports. The firm currently has a sell rating on the stock.
HNR1 has been the topic of a number of other reports. Deutsche Bank restated a hold rating and issued a GBX 1,775 ($23.19) price target on shares of in a research note on Wednesday, June 26th. Goldman Sachs Group set a €40.50 ($47.09) target price on Koninklijke Philips and gave the stock a buy rating in a research report on Tuesday, May 7th. Nord/LB set a €29.30 ($34.07) target price on Aareal Bank and gave the stock a neutral rating in a research report on Thursday, May 9th. UBS Group upgraded to a neutral rating and boosted their target price for the stock from GBX 945 ($12.35) to GBX 2,060 ($26.92) in a research report on Thursday, June 20th. Finally, DZ Bank reiterated a neutral rating on shares of Hannover Re in a research report on Monday, June 24th. Five analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the company’s stock. The stock currently has an average rating of Hold and a consensus target price of €120.66 ($140.30).
Hannover Re stock opened at €142.70 ($165.93) on Monday. Hannover Re has a 1-year low of €94.75 ($110.17) and a 1-year high of €116.37 ($135.31). The company has a 50 day simple moving average of €140.02.
About Hannover Re
Hannover Rück SE, together with its subsidiaries, provides reinsurance products and services worldwide. It operates through Property & Casualty Reinsurance, and Life & Health Reinsurance segments. The Property & Casualty Reinsurance segment offers specialty lines comprising marine, aviation, facultative, credit, surety, and political risks reinsurance products; and treaty, catastrophe XL, and structured reinsurance, as well as insurance-linked securities.
See Also: 52-Week High/Low
Receive News & Ratings for Hannover Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hannover Re and related companies with MarketBeat.com's FREE daily email newsletter.